Oncology Diagnostics

Arterys Inc. announced its fifth 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Arterys Oncology AI Suite, an artificial intelligence (AI)-based, cloud-based medical imaging software.

February 8, 2018 — The U.S. Food and Drug Administration (FDA) and the Nuclear Regulatory Commission (NRC) recently took steps to ensure a stable and secure supply of a critical radioactive imaging tracer used to detect potentially life-threatening diseases.

October 17, 2017 — The American College of Radiology (ACR) recently refined its standardized system for liver cancer screening and surveillance...

The webinar "Multi-Modality 3D Quantitative Imaging in Cancer Care: Clinical Value and Future Perspectives" focuses on the role of image analysis and artificial intelligence for image-guided, minimally invasive cancer therapies.

The number of new cases of metastatic prostate cancer climbed 72 percent in the past decade from 2004 to 2013, reports a new Northwestern Medicine study.